scispace - formally typeset
P

Peter Simmonds

Researcher at University of Oxford

Publications -  857
Citations -  69113

Peter Simmonds is an academic researcher from University of Oxford. The author has contributed to research in topics: Hepatitis C virus & Virus. The author has an hindex of 131, co-authored 823 publications receiving 62953 citations. Previous affiliations of Peter Simmonds include John Radcliffe Hospital & Edinburgh Royal Infirmary.

Papers
More filters
Journal ArticleDOI

Improvements in the determination of sulfur hexafluoride for use as a meterological tracer.

TL;DR: F fluoride separation from aqueous media containing various metallic ions is studied and a complete separation is obtained after addition of DCTA and phosphate buffer to work at a pH value of about 6.5.
Journal ArticleDOI

Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group.

TL;DR: Among 116 patients with biopsy-confirmed chronic hepatitis C in a multicenter study in southern Norway on interferon, hepatitis C virus genotype by restriction fragment length polymorphism (RFLP) of the 5' NCR was determined and the epidemiological features of hepatitis C patients are markedly different from patient groups described in southern Europe.
Journal ArticleDOI

Molecular epidemiology of norovirus in Edinburgh healthcare facilities, Scotland 2007–2011

TL;DR: Investigation of the NoV genotypes responsible for outbreaks in Edinburgh healthcare facilities between June 2008 and July 2011 found increases in NoV activity coincided with the emergence of new GII.4 strains, highlighting the need for an active surveillance system to allow the rapid identification of new strains.
Journal ArticleDOI

Managing patients with lung cancer. New guidelines should improve standards of care.

Peter Simmonds
- 28 Aug 1999 - 
TL;DR: Evidence based clinical practice guidelines such as those recently published by the Royal College of Radiologists' clinical oncology information network (COIN) for the non-surgical management of lung cancer should help clinicians make better decisions, thereby reducing inappropriate variation and improving patient care.